Skip to main content

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Article
  • Cited by 7
  • Cited by
    Crossref Citations
    Crossref logo
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.
    Karam, Chafic and Koussa, Salam 2008. Cerebral dural sinus thrombosis following cisplatin chemotherapy. Journal of Clinical Neuroscience, Vol. 15, Issue. 11, p. 1274.
    Li, Shau-Hsuan Chen, Wei-Hsi Tang, Yeh Rau, Kun-Ming Chen, Yeng-Yang Huang, Tai-Lin Liu, Jia-Shou and Huang, Cheng-Hua 2006. Incidence of ischemic stroke post-chemotherapy: A retrospective review of 10,963 patients. Clinical Neurology and Neurosurgery, Vol. 108, Issue. 2, p. 150.
    Kovács, Adorján F. Turowski, Bernd Ghahremani, Mostafa T. and Loitz, Matthias 1999. Intraarterial chemotherapy as neoadjuvant treatment of oral cancer. Journal of Cranio-Maxillofacial Surgery, Vol. 27, Issue. 5, p. 302.
    Campanella, Nando Ferretti, Maurizio Daher, Walid Pergolini, Martina and De Nictolis, Michele 1999. Combined Malignant Hemangiopericytoma and Deep Venous Thrombosis. A Case Report. Tumori Journal, Vol. 85, Issue. 3, p. 199.
    Fountzilas, George Kosmidis, Paris Avramidis, Vasilios Nikolaou, Angelos Kalogera-Fountzila, Anna Makrantonakis, Paris Bacoyiannis, Charalambos Samantas, Epaminontas Skarlos, Dimosthenis and Daniilidis, John 1997. Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: A hellenic co-operative oncology group study. Medical and Pediatric Oncology, Vol. 28, Issue. 6, p. 401.
    Wang, Hung-Ming Ng, Shu-Hang Wang, Cheng-Hsu Liaw, Chuang-Chi Tsai, Ming-Hsui and Lai, Gi-Ming 1996. Correlation between computed tomographic density of lymph node metastases and response to cisplatin-based chemotherapy in patients with head and neck squamous cell carcinoma in an area in which betel quid chewing is prevalent. Cancer, Vol. 78, Issue. 9, p. 1972.
    Fonseca, Emilio Cruz, J. Jesus Dueñas, Alfonso Gómez, Amalia Sánchez, Pedro Martín, Germán Nieto, Adelaida Soria, Pedro Muñoz, Angel Gómez, J. Luis and Pardal, J. Luis 1996. Do the Conventional Clinicopathologic Parameters Predict for Response and Survival in Head and Neck Cancer Patients Undergoing Neoadjuvant Chemotherapy?. Tumori Journal, Vol. 82, Issue. 6, p. 560.
    ×
  • Get access
    Add to cart USD35.00
    Check if you have access via personal or institutional login
    Log in Register Recommend to librarian

Predictive factors of a complete response to and adverse effects of a CDDP-5FU combination as primary therapy for head and neck aquamous carcinomas

  • J. M. Bachaud (a1), J. M. David (a2), R. E. Shubinski (a1), D. Perineau (a1), G. Boussin (a3), E. Serrano (a4), M. De Forni (a5), J. J. Pessey (a1) and N. J. Daly-Schveitzer (a1)...
Abstract

Abstract: Retrospective analysis of detailed patient and tumour factors associated with a complete response to combination inductive chemotherapy with CDDP-5FU (96 or 120 hour continuous infusion) was performed using data from 147 patients with a previously untreated squamous cell carcinoma of the oral cavity, oropharynx or pharyngo-larynx following completion of two (29 patients) or three (118 patients) cycles. Adverse reactions to chemotherapy were documented for all 164 patients included in the study. Eight drug-related deaths occurred due to: acute myocardial infarction (five patients), peptic ulcer disease (two patients) and severe neutropenia with sepsis (one patient). Severe non-lethal complications included marrow depletion (14 patients), peptic ulcer (two patients), thrombophlebitis (seven patients), angina pectoris (two patients), stroke (one patient), pulmonary oedema (one patient) and convulsions (one patient). Six patients refused further treatment because of untoward side effects and tumoral progression was observed in three cases. Separate response rates for the primary site and nodes were determined and analysis of respective predictive factors of response was performed. Complete response was obtained in 31 per cent at the primary site versus 18 per cent for the nodes (p<0.05). The combined (primary site + nodes) overall complete response rate was 22 per cent. Among 11 factors studied (age, sex, performance status, primary site, tumour differentiation, initial resectability, 5FU dosage per cycle, number of cycles, T, N and TN stages), only performance status, N stage, resectability and number of cycles were associated with a combined complete response. Multivariate analysis showed performance status, N stage, TN stage and resectability to be significant predictive factors of a combined complete response. Optimum use of inductive chemotherapy will ultimately rely upon a better knowledge of predictive factors in order to avoid drug-related complications in patients not expected to respond.

Copyright
COPYRIGHT: © JLO (1984) Limited 1993
Corresponding author
J. M. Bachaud, M.D., Centre Claudius Regaud, 20–24, rue du Pont Saint-Pierre, 31052 Toulouse Cedex, France.
References
Hide All
Al-Sarraf, M. (1987) Timing of chemotherapy as part of multimodality treatment in patients with advanced head and neck cancer. In Cancers of the Head and Neck (Jacobs, C., ed.). Martinus Nijhoff, Boston, pp. 143–154.
Al-Sarraf, M. (1988) Head and neck cancer: chemotherapy concepts. Seminars in Oncology 5: 70–85.
Burger, A., Mannino, S. (1987) 5-Fluorouracil induced coronary vasospasm. American Heart Journal 114: 433–436.
Cognetti, F., Pinnaro, P., Ruggeri, E. M., Carlini, P., Perrino, A., Impiombato, F. A., Calabresi, F., Chilelli, M. G., Giannarelli, D. (1989) Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer. Journal of Clinical Oncology 7: 829–837.
Collins, C., Welden, P. L. (1987) Cardiotoxicity of 5-fluorouracil. Cancer Treatment Reports 71: 733–736.
de Forni, M., Malet-Martino, M. C., Jaillais, P., Schubinski, R. E., Bachaud, J. M., Lemaire, L., Canal, P., Chevreau, C., Carrié, D., Soulié, P., Roché, H., Boudjema, B., Mihura, J., Martino, R., Bernadet, P., Bugat, R. (1992) Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical trial. Journal of Clinical Oncology 10: 1795–1801.
Demard, F., Chauvel, P., Santini, J., Vallicioni, J., Thyss, A., Schneider, M. (1990) Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas. Head and Neck 12: 255–231.
Ensley, J. F., Jacobs, J. R., Weaver, A., Kinzie, J., Crissman, J., Kish, J. A., Cummings, G., Al-Sarraf, M. (1984) Correlation between response to cisplatinum combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54: 811–814.
Ervin, T. J., Clark, J. R., Weichselbaum, R. R., Fallon, B. G., Miller, D., Fabian, R. L., Posner, M. R., Norris, C. M., Tuttle, S. A., Schoenfeld, D. A., Price, K. N., Frei, E. III (1987) An analysis of induction and adjuvant chemotherapy in the multidisdiplinary treatment of squamous cell carcinoma of the head and neck. Journal of Clinical Oncology 5: 10–20.
Eskilsson, J., Albertsson, M., Mercke, C. (1988) Adverse cardiac effects during induction chemotherapy treatment with cisplatin and 5-fluorouracil. Radiotherapy and Oncology 13: 41–46.
Gradishar, W. J., Vokes, E. E. (1990) 5-Fluorouracil cardiotoxicity: a critical review. Annals of Oncology 1: 409–414.
Hass, C., Byhardt, R., Cox, J., Duncavage, J., Grossman, T., Haas, J., Hartz, A., Libnoch, J., Malin, T., Ritch, P., Toohill, R. (1985) Randomized study of 5-fluorouracil and cis-platinum as initial therapy of locally advanced squamous carcinoma of the head and neck: a preliminary analysis. Proceedings of the American Society of Clinical Oncology 4: 143.
Hill, B. T., Price, L. A., MacRae, K. (1986) Importance of primary site in assessing chemotherapy response and 7-year survival data in advanced squamous-cell carcinomas of the head and neck treated with initial combination chemotherapy without cisplatin. Journal of Clinical Oncology 4: 1340–1347.
Hong, W. K., Wolf, G. T., Fisher, S., Spaulding, M., Endicott, J., Laramore, G., Hillman, R., McClatchey, K., Fye, C. (1989) Laryngeal preservation with induction chemotherapy and radiotherapy in the treatment for advanced laryngeal cancer: interim survival data of VACSP 268. VA Laryngeal Cancer Study Group. Proceedings of the American Society of Clinical Oncology 8: 167.
Jacobs, C., Wolf, G. T., Makuch, R. W., Vikram, B. (1984) Adjuvant chemothapy for head and neck squamous carcinomas. Proceedings of the American Society of Clinical Oncology 3: 182.
Jacobs, C., Goffinet, D. R., Goffinet, L., Kohler, M., Fee, W. E. (1987a) Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer: a report from the Northern California Oncology Group. Cancer 60: 1178–1183.
Jacobs, J. R., Weaver, A., Ahmed, K., Crissman, J., Ensley, J. F., Kish, J. A., Cummings, G., Al-Sarraf, M. (1987a) Proto-chemotherapy in advanced head and neck cancer. Head and Neck Surgery 10: 93–98.
Johnson, J. T., Mayernik, D. G., Myers, E. N., Nolan, T. A., Schramm, V. L., Sigler, B. A., Wagner, R. L. (1987) Cisplatin and fluorouracil chemotherapy for advanced inoperable squamous carcinoma of the head and neck. Head and Neck Surgery 9: 336–340.
Kies, M. S., Gordon, L. I., Hauck, W. W., Krespi, Y., Ossoff, R. H., Pecaro, B. C., Yuska, C., Lamut, C. H., Brand, W. N., Chang, S.K., Shetty, R., Sisson, G. A. (1985) Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer. Otolaryngology: Head and Neck Surgery 93: 199–205.
Martin, M., Hazan, A., Vergnes, L., Peytral, C., Mazeron, J. J., Sénéchaut, J. P., Lelièvre, G, Peynègre, R. (1990) Randomized study of 5-fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: a preliminary report. International Journal of Radiation, Oncology. Biology, Physics 19: 973–975.
Million, R. R., Cassisi, N. J., Wittles, R. E. (1985) Cancer in the head and neck. In Cancer: Principles and Practices of Oncology (De Vita, V. T., Hellman, S., Rosenberg, S. A., eds.). J. B. Lippincott. Philadelphia, pp. 488–590.
Mohit-Tabatai, M. A., Hill, G. J., Raina, S., Rush, B. F., Ohanian, M. (1990) Multimodality preoperative treatment for advanced stage IV (M0) cancer of the head and neck. American Journal of Surgery 160: 370–372.
Nakashima, T., Maehara, Y., Kohnoe, S., Hayashi, I., Katsuta, Y. (1990) Histologic differentiation and chemosensitivity of human head and neck squamous cell carcinomas. Head and Neck 12: 406–410.
Rezkalla, S., Kloner, R. A., Ensley, J., Al-Sarraf, M., Revels, S., Olivenstein, A., Bhasin, S., Kerpel-Fronious, S., Turi, Z. G. (1989) Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. Journal of Clinical Oncology 7: 509–514.
Rooney, M., Kish, J., Jacobs, J., Kinzie, J., Weaver, A., Crissman, J., Al-Sarraf, M. (1985) Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 55: 1123–1128.
Schuller, D. E., Metch, B., Stein, D. W., Mattox, D., McCracken, J. D. (1988) Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope 98: 1205–1211.
Shapshay, S. M., Hong, W. K., Incze, J. S., Sismanis, A., Bhutani, R., Vaughn, C. W., Strong, M. S. (1980) Prognosis indicators in induction cisplatin—bleomycin chemotherapy for advanced head and neck cancer. American Journal of Surgery 140: 543–548.
Tannock, I. F., Browman, G. (1986) Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. Journal of Clinical Oncology 4: 1121–1126.
Taylor, S. G., Applebaum, E., Showel, J. L., Norusis, M., Holinger, L. D., Hutchinson, J. C., Murthy, A. K., Caldarelli, D. D. (1985) A randomized trial of adjuvant chemotherapy in head and neck cancer. Journal of Clinical Oncology 3: 672–679.
Tennvall, J., Albertsson, M., Biörklund, A., Wennerberg, J., Anderson, H., Andersson, T., Elner, A., Mercke, C. (1991) Induction chemotherapy (cisplatin + 5-fluorouracil) and radiotherapy in advanced squamous cell carcinoma of the head and neck. Acta Oncologica 30: 27–32.
Thyss, A., Schneider, M., Santini, J., Caldini, C., Vallicioni, J., Chauvel, P., Demard, F. (1986) Induction chemotherapy with cisplatinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. British Journal of Cancer 54: 755–760.
Vokes, E.Moran, W.JMick, R., Weichselbaum, R.R., Panje, W. R. (1989) Neoadjuvant and adjuvant methotrexate, cisplatin and fluorouracil in multimodal therapy of head and neck cancer. Journal of Clinical Oncology 7: 838–845.
Weaver, A., Fleming, S., Ensley, J., Kish, J. A., Jacobs, J., Kinzie, J., Crissman, J., Al-Sarraf, M.. (1984) Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer. American Journal of Surgery 148: 525–529.
Wolf, G. T., Makuch, R. W., Baker, S. R. (1984) Predictive factors for tumor response to preoperative chemotherapy in patients with head and neck squamous carcinoma. The Head and Neck Contracts Program. Cancer 54: 2869–2877.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *

CAPTCHA *

Skip to the audio challenge
×

Keywords:

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 1 *
Loading metrics...

Abstract views

Total abstract views: 41 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 13th June 2018. This data will be updated every 24 hours.

Cancel
Confirm
×